Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
MDxHealth Contracts with Priority Health for Coverage of ConfirmMDx
IRVINE, CA, and HERSTAL, BELGIUM – June 23, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced that it has contracted with Priorit
MDxHealth Announces Agreement with Major Academic Medical Center for ConfirmMDx Testing
IRVINE, CA, and HERSTAL, BELGIUM – June 21, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today that it has entered into an a
MDxHealth : Extraordinary General Shareholders’ Meeting
IRVINE, CA, and HERSTAL, BELGIUM, 20 June 2016 -MDxHealth SA (NYSE Euronext: MDXH.BR), held its Extraordinary General Meeting of S
MDxHealth Announces European Urology Editorial Supporting SelectMDx Use in Detecting Prostate Cancer
IRVINE, CA, and HERSTAL, BELGIUM – June 16, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today the publication of an editori
MDxHealth (R): Grants QIAGEN Rights to MSP Technology for QIAsure Methylation Test for Cervical Cancer Risk
IRVINE, CA, and HERSTAL, BELGIUM – June 15, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today that it has granted a non-exc
MDxHealth Holds Capital Markets Day in New York City
Key Opinion Leaders Highlight MDxHealth’s Commercial Portfolio IRVINE, CA, and HERSTAL, BELGIUM – June 14, 2016 – MDxHealth SA (
MDxHealth Secures First Reimbursement Coverage for SelectMDx
IRVINE, CA, and HERSTAL, BELGIUM – June 14, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today that it has secured the first
Annual General Shareholders’ Meeting
Irvine, CA, and Herstal, BELGIUM – May 27, 2016 – MDxHealth SA (Euronext: MDXH), held today its Annual General Shareholders’ Meeti
MDxHealth (R): Disclosure of the Number of Outstanding Voting Securities
IRVINE, CA and HERSTAL, BELGIUM, May 20, 2016 – MDxHealth SA (NYSE Euronext: MDXH) (“MDxHealth”) announced today, pursuant to Arti
MDxHealth’s ConfirmMDx Stratifies Risk for Aggressive Prostate Cancer
Multicenter validation study published in the journal The Prostate IRVINE, CA, and HERSTAL, BELGIUM – May 9, 2016 – MDxHealth SA
MDxHealth Announces Positive Data Supporting Prognostic Value of ConfirmMDx and SelectMDx for Prostate Cancer
Data are Presented at the American Urological Association Annual Meeting, 6-10 May 2016, San Diego IRVINE, CA, and HERSTAL, BELG
MDxHealth Provides First Quarter 2016 Business Update
Revenue Increased 66% Over First Quarter 2015 IRVINE, CA, and HERSTAL, BELGIUM – May 3, 2016 – MDxHealth SA (Euronext: MDXH.BR) t
MDxHealth’s SelectMDx Study Published in European Urology
Data validates ‘liquid biopsy’ test’s ability to identify men at risk for aggressive cancer IRVINE, CA, and HERSTAL, BELGIUM –
MDxHealth Partners with Andros Men’s Clinic to Offer SelectMDx for Prostate Cancer
IRVINE, CA, and HERSTAL, BELGIUM – March 29, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today that it has partnered with A
MDxHealth Launches SelectMDx “Liquid Biopsy” Test in the United States
Non-invasive, urine-based prostate cancer assay available as a laboratory developed test IRVINE, CA, and HERSTAL, BELGIUM – Mar
MDxHealth Presents SelectMDx(TM) Results from Multicenter Validation Study at the 2016 Annual EAU Congress
SelectMDx awarded best poster presentation by EAU’s Scientific Congress Office IRVINE, CA, and HERSTAL, BELGIUM – March 14, 2016
MDxHealth Appoints Global Commercial Team for SelectMDx
IRVINE, CA, and HERSTAL, BELGIUM – March 9, 2016 – MDxHealth SA (Euronext: MDXH.BR) announced today that it has appointed a global
MDxHealth Announces Inclusion of ConfirmMDx in 2016 NCCN Guidelines for Prostate Cancer Early Detection
IRVINE, CA, and HERSTAL, BELGIUM – March 2, 2016 – MDxHealth SA (Euronext: MDXH.BR), today announced that its ConfirmMDx® for Pro
MDxHealth Reports Fourth Quarter and Fiscal Year 2015 Results
Full Year ConfirmMDx Revenue up 62% Compared to Full Year 2014 IRVINE, CA, and HERSTAL, BELGIUM – 7:00 AM, February 18, 2016 – M
MDxHealth Announces Conference Participation for First Half 2016
IRVINE, CA, and HERSTAL, BELGIUM – January 28, 2016 – MDxHealth SA (Euronext: MDXH.BR), announced today that it will be participat